Authors


Jennifer Riggs-Sauthier

Latest:

The Benefits and Challenges of PEGylating Small Molecules

Polyethylene glycol (PEG) conjugation is a highly effective technical and commercial strategy to develop macromolecules. The authors explain the benefits and process of PEGylation and how it may be applied to small molecules.


Heinz Sucker

Latest:

Suppositories: The Incomplete Story

A reference book omits important information and ignores advanced testing procedures.


Marlene Kim

Latest:

Master File Submission of Structures

The SD File format offers benefits for KASA and cheminformatics to support regulatory submissions.


Andrew Birkmire

Latest:

Optimizing Loss-in-Weight Feeding of Poorly Flowing Materials

Prior to use in a continuous manufacturing system for oral solid dosage forms, loss-in-weight feeders need to be tested and validated to understand the performance capabilities of a given material–feeder combination. In this article, the proper strategy for set-up and optimization of a loss-in-weight feeder is demonstrated for a range of materials. The optimized set-up of the feeders was demonstrated to provide suitable performance for even the most challenging, poorly flowing materials.


Jnanadeva Bhat

Latest:

Pelletization: Revolutionizing Drug Formulation and Delivery

Pelletization, a popular oral drug delivery method in pharmaceuticals and nutraceuticals, offers numerous benefits. This article delves into the critical parameters for formulation development and technological consideration in pelletization, elucidating its significance in advancing pharmaceutical solutions.


Piet Christiaens

Latest:

Extractable and Leachable Challenges in Lyophilized Drug Products

The authors examine the risks of extractables and leachables, and present solutions that emphasize the importance of a strategic, multi-prong approach.


Barbara Fretter

Latest:

Handling Challenging Powders in Tableting Operations

Tests evaluated commercial rotary tablet presses to see how effectively they deal with problems such as poor flow, overlubrication, and capping.


Matthew Pincus

Latest:

Digitalization of QbD Risk Assessments

Quality-by-design risk assessment workflows can be laborious and have limited capacity to connect with vast volumes of prior knowledge generated by organizations. Their digital transformation can improve efficiency, reduce human errors, and facilitate integration within a much broader digital ecosystem.


Daria G. Husni

Latest:

Dissecting Dissolution Testing

Advances in dissolution testing equipment are helping to meet user demands to a certain degree; however, more innovation in the space may be necessary for novel therapies, such as biologics.


Adela Kasselkus

Latest:

Seven Trends Shaping the Future of Pharmaceutical Formulation Development

Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.


SCORR Marketing

Latest:

Strategic Insights for 2025

Alec McChesney (BD Director, SCORR Marketing) discusses goal setting and alignment between life sciences marketing and business development teams.


David Green

Latest:

Master File Submission of Structures

The SD File format offers benefits for KASA and cheminformatics to support regulatory submissions.


James M. Prendergast

Latest:

EPCAM: A Strategy to Enable Manufacturing-Process Control Transformation

Enterprise process control and management (EPCAM) is a new strategy for healthcare manufacturers based on recent process-control breakthroughs in the electronics industry.


suez

Latest:

2020 Bio/Pharma Virtual Congress

*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021


Alex Praseuth

Latest:

Considerations for Monoclonal Antibody Bioprocess and Manufacturing Validation

Regulatory, analytical, and process concerns must be taken into account.


Scitara

Latest:

MOBILIZE YOUR DATA. MODERNIZE YOUR LAB.

Thursday October 27, 2022 at 11am ET | 10am CT | 8am PT When it comes to freely accessing and sharing lab data, there’s a lot working against you out there. To create infrastructure that truly mobilizes your data and modernizes your lab, you need a new kind of solution.


Tola Olorunnisola

Latest:

Lab Digitalization: From Source to Scientist

Integrating digital technologies into lab environments can ease workflow and enhance data capture for researchers.


Mark Stevens

Latest:

Lean Compliance And Adopting A True Risk-Based Approach To Validation

With the increasing need for businesses to reduce costs and demonstrate value, there is a requirement to look at all aspects of bio/pharma drug development and manufacturing to achieve efficiency improvements.


Peter Langguth

Latest:

The New EMA Bioequivalence Guideline: Key Considerations

A new guideline for conducting bioequivalence studies was adopted by the CPMP in January and it becomes fully effective as of August 2010.


Flora J. Keumurian

Latest:

The Impact of SARS-CoV-2 on Biomanufacturing Operations

This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.


Kate Rice

Latest:

Focusing on Effectiveness for CAPAs

Compliance can be greatly improved by concentrating on the basic elements of CAPA investigations, advises Kate Rice, global quality systems manager, Nelson Laboratories, and Susan J. Schniepp, distinguished fellow, Regulatory Compliance Associates.


Richard Montes

Latest:

Comparing Methods for Determining Out-of-Trend Stability Test Results

This article describes in detail how simulation was used to compare the statistical techniques used to determine out-of-trend (OOT), which is crucial to avoiding out-of-specification (OOS) events for drug substances and products.


Apoorva Panda

Latest:

Evaluating the Impact of Fatty Alcohols on Permeation of Clotrimazole from Topical Creams

Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.


Pyxant

Latest:

Buy vs. Build: Bioanalytical lab

With so many outsourcing/insourcing options across drug development workflows, pharmaceutical companies are faced with finding the right partner to fit the needs of their unique molecule. There are criteria to consider when outweighing the benefits and risks associated with buying or building a bioanalytical lab.


Parth Soni

Latest:

ECHA’s Microplastics Use Restriction—Impact on Pharmaceuticals

To restrict the use of intentionally added microplastics, the European Chemicals Agency has proposed a restriction dossier that describes various measures aimed at minimizing the use of microplastics in various industrial segments, including pharmaceuticals. In this paper, the authors discuss these restrictions.



West Pharmaceutical Services

Latest:

Vial Adapter Considerations for Cell and Gene Therapy Applications

The landscape of cell and gene therapy is rapidly evolving, with increasing approvals for diverse indications. Preserving the integrity and efficacy of cell and gene therapy products is critical. Vial adapters facilitate the transfer of drug product from a vial by securing an efficient connection between the vial and the administration device. Learn more about how sterility and accurate dosing are maintained while preserving stability.


Lawrence Feeley

Latest:

Determining Low PPB Levels of Nitrite in Polymeric Excipients

In this paper, the authors introduce a method that combines ion exchange chromatography with an easier-to-perform, simpler one-step post-column derivatization that is selective to nitrite and visible spectrophotometric detection to allow high sample loading volumes without affecting resolution.


John Palmer

Latest:

Optimizing Loss-in-Weight Feeding of Poorly Flowing Materials

Prior to use in a continuous manufacturing system for oral solid dosage forms, loss-in-weight feeders need to be tested and validated to understand the performance capabilities of a given material–feeder combination. In this article, the proper strategy for set-up and optimization of a loss-in-weight feeder is demonstrated for a range of materials. The optimized set-up of the feeders was demonstrated to provide suitable performance for even the most challenging, poorly flowing materials.


Renato Rjavec

Latest:

What DADI Means for the Pharmaceutical Industry

The move toward using the Digital Application Dataset Integration (DADI) project for the initial implementation of IDMP-based regulatory data submissions offers both opportunities and challenges for pharmaceutical organizations.